Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages
出版年份 2015 全文链接
标题
Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages
作者
关键词
<em class=EmphasisTypeItalic >KRAS</em> mutation, <em class=EmphasisTypeItalic >BRAF</em> mutation, Colorectal cancer, Codon 12 and 13, DNA mismatch repair
出版物
BMC CANCER
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-05-01
DOI
10.1186/s12885-015-1345-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
- (2014) J. Goldstein et al. ANNALS OF ONCOLOGY
- Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
- (2014) H. Blons et al. ANNALS OF ONCOLOGY
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF-Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)
- (2014) H. H. Yoon et al. CLINICAL CANCER RESEARCH
- The prognostic role of microsatellite instability, codon-specificKRAS, andBRAFmutations in colon cancer
- (2014) Chun-Chi Lin et al. JOURNAL OF SURGICAL ONCOLOGY
- Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147
- (2014) Wilson I. Gonsalves et al. JNCI-Journal of the National Cancer Institute
- Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer
- (2014) Geraldine Perkins et al. PHARMACOGENOMICS
- BRAFV600E Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2014) Dong Chen et al. PLoS One
- Clinical relevance of KRAS mutations in codon 13: Where are we?
- (2013) Tze-Kiong Er et al. CANCER LETTERS
- Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
- (2013) Christophe Rosty et al. MODERN PATHOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations
- (2013) Chih-Chieh Chen et al. PLoS One
- The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis
- (2013) Zi-Xu Yuan et al. PLoS One
- BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon
- (2012) Reetesh K. Pai et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- KRASp.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer
- (2012) Chen Mao et al. CANCER
- Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers
- (2012) Y. Imamura et al. CLINICAL CANCER RESEARCH
- KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer
- (2012) Chen Mao et al. PLoS One
- Molecular Genetics of Colorectal Cancer
- (2011) Eric R. Fearon Annual Review of Pathology-Mechanisms of Disease
- Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients
- (2011) Hong Shen WORLD JOURNAL OF GASTROENTEROLOGY
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
- (2010) S. Ogino et al. GUT
- Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer
- (2010) Inti Zlobec et al. INTERNATIONAL JOURNAL OF CANCER
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
- (2010) Wendy De Roock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
- (2009) Nicola Normanno et al. Nature Reviews Clinical Oncology
- BRAFMutation in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer
- (2009) Winder ONCOLOGY REPORTS
- Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
- (2008) A. J. French et al. CLINICAL CANCER RESEARCH
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- (2008) S. Ogino et al. GUT
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Classification and Correlates in Colorectal Cancer
- (2007) Shuji Ogino et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation